Pyogenic Spondylitis in Elderly Patients

Pyogenic spondylitis is a rare and probably under- diagnosed condition (incidence: 2 to 3 out of every 100,000 people in Europe). It is more common among elderly patients over the age of 60, and its prevalence increases with age. It represents 2 to 4% of osteoarticular infections. Phy- siopathologically, we should differentiate between haemato- genous spondylitis, which occurs with septicaemia with secondary grafting on the spine and which is the most common, and secondary or contiguous spondylitis, which arises in a postoperative context or after a procedure on the spine such as infiltration, and affects younger patients. The clinical presentation is aspecific and often torpid, with an absence of fever in half of all cases. The most frequent symp- tom is spinal pain. CRP is generally heightened, averaging at around 120 mg/l. The bacteria most frequently responsible for spondylitis are staphylococcus and streptococcus. The microbiological documentation on spondylitis is a signifi- cant way of being able to conduct treatment and adapt it in the event of intolerance. There are three vectors for the treatment of this condition: antibiotic therapy, surgery and immobilisation. The prognosis for this condition is good, including in elderly patients, and neurological complications are rare. These appear to be characteristic of Mycobacte- rium tuberculosis (not dealt with here) and Staphylococ- cus aureus infections.

[1]  M. Perelman,et al.  The unique clinical features and outcome of infectious endocarditis and vertebral osteomyelitis co-infection. , 2014, The American journal of medicine.

[2]  M. Dupon,et al.  Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-biopsy blood cultures , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  P. Hoffmeyer,et al.  Epidemiology of adverse events and Clostridium difficile-associated diarrhea during long-term antibiotic therapy for osteoarticular infections. , 2013, The Journal of infection.

[4]  Chien-Chang Lee,et al.  The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  M. Assal,et al.  Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections. , 2010, Swiss medical weekly.

[6]  Alpesh A. Patel,et al.  Vertebral Osteomyelitis , 2010 .

[7]  J. Desenclos,et al.  Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2003 , 2007, Epidemiology and Infection.

[8]  A. Feydy,et al.  Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis. , 2006, Rheumatology.

[9]  P. Huddleston,et al.  Do follow-up imaging examinations provide useful prognostic information in patients with spine infection? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  V. Falcó,et al.  Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. , 2005, The American journal of medicine.

[11]  M. Paccalin,et al.  Clinical and Laboratory Characteristics of Infective Endocarditis When Associated with Spondylodiscitis , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[12]  E. Carragee The Clinical Use of Magnetic Resonance Imaging in Pyogenic Vertebral Osteomyelitis , 1997, Spine.

[13]  R. Flipo,et al.  Streptococcal and enterococcal spondylodiscitis (vertebral osteomyelitis). High incidence of infective endocarditis in 50 cases. , 2006, The Journal of rheumatology.

[14]  R. Queiró,et al.  Haematogenous Vertebral Osteomyelitis in the Elderly , 2000, Clinical Rheumatology.